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Abstract Surf1p is a protein involved in the assembly of
mitochondrial respiratory chain complexes. However its exact
role in this process remains to be elucidated. We studied SHY1,
the yeast homologue of SURF1, with an aim to obtain a better
understanding of the molecular pathogenesis of cytochrome c
oxidase (COX) deficiency in SURF1 mutant cells from Leigh
syndrome patients. Assembly of COX was analysed in a shy1 null
mutant strain by two-dimensional polyacrylamide gel electro-
phoresis (2D-PAGE). Steady-state levels of the enzyme were
found to be strongly reduced, the total amount of assembled
complex being approximately 30% of control. The presence of a
significant amount of holo-COX in the SHY1-disruptant strain
suggests that Shy1p may either facilitate assembly of the
enzyme, or increase its stability. However, our observations,
based on 2D-PAGE analysis of mitochondria labelled in vitro,
now provide the first direct evidence that COX assembly is
impaired in a vshy1 strain. COX enzyme assembled in the
absence of Shy1p appears to be structurally and enzymically
normal. The in vitro labelling studies additionally indicate that
mitochondrial translation is significantly increased in the shy1
null mutant strain, possibly reflecting a compensatory mecha-
nism for reduced respiratory capacity. Protein interactions of
both Shy1p and Surf1p are implied by their appearance in a high
molecular weight complex of about 250 kDa, as shown by 2D-
PAGE. ß 2001 Federation of European Microbiological Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Cytochrome c oxidase (COX) catalyses the ¢nal step of the
respiratory chain in which oxygen is reduced to water [1]. This
reaction is important for the generation of energy but must be
well controlled, because escape of reactive oxygen can occur
as an unwanted side product [2]. Proper function of COX
therefore involves propagation of the enzyme reaction in
which electrons are transferred to oxygen, as well as prevent-
ing the escape of toxic intermediates.
COX contains 13 subunits of which the three largest are
encoded by the mitochondrial genome [3]. Irrespective of their
coding sequence, all subunits of the complex are guided to the
mitochondrial inner membrane and positioned in the appro-
priate orientation. Beside these protein subunits, also two
heme groups and several metal ions have to be incorporated
to obtain a functional complex [3].
A surprisingly large number of factors is needed for the
proper assembly of COX ([4] for review). Characterisation
of yeast cells de¢cient in COX activity has led to the identi-
¢cation of a number of genes whose products are required for
wild-type function of the enzyme. Proteins involved in the
maturation of heme (COX10, COX11) [5] and in the incorpo-
ration of copper atoms (SCO1, SCO2 and COX17) [6] have
been identi¢ed. OXA1 appeared to be required for obtaining
the correct membrane orientation of Cox2p [7]. However the
role and mechanism of action of most of the assembly factors
including COX18, COX20, PET197, COX14, COX15 and
SHY1 remain to be elucidated.
Human homologues of most of the yeast COX assembly
factors have been found. Mutations in SCO1 [8], SCO2 [9],
COX10 [10] and SURF1 [11,12] have been linked to di¡erent
human diseases. Leigh syndrome caused by mutations in
SURF1 (the human homologue of the yeast gene SHY1) is
by far the most frequently reported defect and is characterised
by a de¢ciency in COX activity [11,12].
The SURF1 gene is highly conserved in a number of species
[13]. The protein is located in mitochondria where it is prob-
ably anchored to the mitochondrial inner membrane by two
transmembrane domains [11,14]. A construct containing only
the two transmembrane helices and the central domain was
able to compensate for the COX negative phenotype [14].
Although it is likely that SURF1 a¡ects the stability and or
assembly of COX [15], its exact role remains so far unclear.
The yeast homologue of SURF1 (SHY1) was originally found
to be a mitochondrial protein required for respiration. A
vshy1 strain displays in addition to a partial COX de¢ciency
an elevated concentration of cytochrome c and an increased
complex III activity [16]. Therefore in contrast to human
SURF1, SHY1 was not solely linked with COX. Together
with the lack of complementation of a SHY1 deletion strain
by SURF1 this has led to the suggestion that Shy1p and
Surf1p may perform similar, but non-overlapping functions
[14]. However this needs not necessarily be so. The sequence
similarity between human SURF1 and yeast SHY1, especially
of some conserved domains is particularly striking [13] and
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several factors might contribute to the lack of species exchan-
geability. Changes in cytochrome c concentration and com-
plex III activity might re£ect a compensatory mechanism in
yeast.
To obtain insight in the molecular action of SURF1 we
studied the yeast homologue SHY1 [16] and compared our
¢ndings with the situation in man. In this study we addressed
two main questions. First, in what way does Shy1p a¡ect
assembly, stability or intrinsic activity of COX? Second,
does Shy1p act as a monomer or is there association with
other components involved in the COX assembly process?
Using blue native two-dimensional polyacrylamide gel elec-
trophoresis (2D-PAGE) we demonstrate that there is a re-
duced amount of fully assembled COX in a vshy strain.
Pulse-chase experiments using radioactive methionine show
that this decrease is caused by a slower assembly. Still there
is a signi¢cant amount of fully assembled COX present which
has normal electron transfer activity. When assessing the mo-
lecular weight of Shy1p with 2D-PAGE Shy1p ran as a mono-
mer, dimer and as a high molecular weight complex of ap-
proximate 250 kDa. Similar results were obtained using
human cells.
2. Materials and methods
2.1. Cell lines, strains and media
Crude mitochondria from patients with Leigh syndrome and from
healthy individuals were used in the study [15]. The Saccharomyces
cerevisiae strain was W303/1A with the nuclear genotype: MATa,
ade2-1, his3-11, -15, leu2-3, -112, ura3-1, trp1-1[b] and its disruptant
shy1: :URA3. Yeast cells were grown in YPGal (2% galactose, 1%
peptone, 1% yeast extract). Solid media contained 2% agar. The stan-
dard temperature for yeast growth was 28‡C.
Escherichia coli strain DH5K was used [17]. E. coli cells were grown
in LB medium (1% bactotryptone, 0.5% yeast extract, 1% NaCl) sup-
plemented with ampicillin (100 Wg/ml) when necessary for plasmid
selection.
2.2. Generation of SHY1-HA and SURF1 containing yeast expression
vectors
Human SURF1 cDNA [15] was cloned into p425TEF [18]. SHY1
was ampli¢ed by means of PCR on chromosomal DNA (S. cerevisiae
FY 1679-28C) using the primers 5P-GGG GAC TAG TTT AAT TAA
GAT GTC TCT ACT AGG CGC CAG-3P and 5P-CCC GGC GGC
CGC CGC CGC GCC CAT ATA TTT CCT TGA ATG CTT-3P.
The introduced restriction sites SpeI and NotI were used to ligate this
fragment into pGH4 [19], a modi¢ed version of p413TEF [18] which
already contained an in-frame GFP-HA sequence. In a next step the
GFP fragment could be removed by deleting an AscI fragment.
2.3. Electrophoresis, Western blotting and ‘in-gel activity’
Standard sodium dodecyl sulphate (SDS)^PAGE was performed
according to Laemmli [20] and 2D-PAGE was done by the method
of Scha«gger and von Jagow [21]. We used a 10 kDa protein ladder as
reference (Gibco). Following electrophoresis, proteins were blotted to
nitrocellulose [22]. Immunoreactive material was visualised by chemo-
luminescence (ECL1, Amersham) according to the instructions of the
manufacturer. In-gel activity assays were performed as described by
Zerbetto and colleagues [23].
2.4. Preparation of mitochondrial fractions for blue native
polyacrylamide gel electrophoresis (BN-PAGE)
The crude mitochondrial pellets of human ¢broblasts were prepared
using digitonin [24]. Yeast cells were grown on 20 ml YPGal medium
(1% yeast extract, 1% peptone, 2% galactose) overnight to an OD600
of approximately 2.0. Mitochondrial pellets were prepared using glass
beads to break the yeast cells followed by di¡erential centrifugation
[25]. Mitochondrial pellets were stored at 370‡C until further process-
ing for 2D-PAGE.
2.5. Antibodies
Polyclonal antiserum against Shy1p was kindly donated by Dr. A.
Tzagolo¡ [16] and the polyclonal antibody used against Surf1p was
described by Tiranti and colleagues [15]. Yeast prohibitin antibody
was as described before [26]. The monoclonal antibody 12CA5 for
the detection of HA-tagged SHY1 was obtained from Boehringer
Mannheim. The monoclonal antibodies to yeast subunits Cox1p,
Cox2p, Cox3p and Cox4p as well as the monoclonal antibodies to
human subunits Cox1p and Cox2p were obtained from Molecular
Probes.
2.6. Pulse-chase experiments
Pulse-chase experiments in isolated mitochondria were performed
as described before [25]. In brief, isolated mitochondria were incu-
bated in optimised protein-synthesising medium D in the presence
of 8 Wl/ml TRAN35S-LABEL1 (1175 Ci/mmol; 10.5 mCi/ml; contain-
ing 70% L-[35S]methionine and 15% L-[35S]cysteine; ICN Biomedicals,
Inc.). Labelling was allowed to continue for 30 min and 250 Wl sam-
ples were taken at 10 min and 30 min. An excess of cold methionine
(¢nal concentration 0.2 M) was added after 30 min to start the chase.
Samples were taken at 30 min and 60 min chase. Pulse-chase experi-
ments in whole cells were performed using cycloheximide to stop
cytoplasmic translation [25]. In short, pulse labelling was started by
adding [35S]methionine to a ¢nal concentration of 50 WCi per ml.
After 30 min cells were collected by centrifugation and washed twice.
Cells were chased by adding excess unlabelled methionine. Mitochon-
drial fractions for BN-PAGE were prepared as described above.
2.7. Miscellaneous
E. coli transformations were carried out by electroporation with the
E. coli pulser (Bio-Rad). S. cerevisiae was transformed by using the
one-step method [27].
3. Results and discussion
Shy1p was ¢rst characterised as a protein required for res-
piration in yeast [16]. Database comparison revealed similarity
to one of a set of genes present in an evolutionarily conserved
cluster known as SURF. SHY1 is a yeast homologue of
SURF1. The product of this gene is known to be involved
in the biogenesis of COX, since Leigh patients with de¢ciency
in the enzyme possess a mutated form of the gene [12]. Di¡er-
ences exist in phenotypes of a yeast vshy1 mutant and Leigh
patients, but the degree of protein sequence conservation sug-
gests that both Shy1p and Surf1p play largely similar if not
identical roles in COX biogenesis. Whether they are required
primarily for assembly or maintaining stability of assembled
complex is not known as is also the exact role played by either
protein.
The steady-state levels of assembled COX in a vshy1 strain
and in a wild-type strain were analysed by 2D-PAGE (Fig. 1).
The disruptant strain contains a complex that according to its
migration in a native gel exactly resembles the fully assembled
complex. This complex contains at least subunits I, II, and III
(Fig. 1), and therefore very likely represents fully assembled
COX. Low molecular weight immunoreactive material was
clearly increased in the disruptant strain (indicated in Fig.
1). These species likely represent unassembled or partially de-
graded subunits. The strong signal in the upper part of the gel
from vshy1 likely comes from Cox1p aggregates. In bovine
COX it is well documented that hydrophobic COX subunits
especially Cox1p and Cox3p tend to aggregate, even in the
presence of SDS [28]. In contrast to the situation in yeast, in
human patient ¢broblasts there are signi¢cant amounts of
partially assembled intermediates present. Yeast may be better
in degrading redundant possibly harmful assembly intermedi-
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ates or the lack of assembly intermediates might simply re£ect
di¡erences in stability during the isolation procedure.
The amount of this holo-COX is approximately 30% of
wild-type cells. This result is in line with the measured enzyme
activity of COX which is also approximately 30% of the wild-
type strain [16]. Fully assembled COX can also be found in
Leigh patient ¢broblasts albeit at reduced levels [15]. Since the
amount of fully assembled COX and residual enzyme activity
are both reduced to approximately 30% of the control, the
reduced enzymatic activity appears to be due to a decrease
in protein amount rather than an altered intrinsic COX activ-
ity. To test this we performed an in-gel activity assay as de-
scribed by Zerbetto and colleagues [23]. A blue native gel
containing vshy1 and wild-type samples was cut into two
halves. The lower half was incubated with substrates for his-
tological staining for COX and the top half of the gel was
incubated with substrates for complex V staining (Fig. 2A).
The speci¢c bands were quanti¢ed by scanning and the per-
centage of COX activity as a percentage of ATPase activity
(internal control) was found to be 36% of the wild-type (Fig.
2B). This is comparable with the di¡erences in amounts of
fully assembled complex. We therefore conclude that the elec-
tron transfer activity of COX in a vshy1 strain is normal and
that assembly occurs to what in all other respects appears to
be a normal enzyme.
Synthesis and turnover of mitochondrially encoded subunits
were studied by pulse-chase labelling in isolated mitochondria.
In the vshy cells there was a remarkable increase of newly
synthesised mitochondrial subunits (Fig. 3A). When the
same blot was probed with antibodies against COX subunits,
the steady-state levels appeared to be as expected namely there
is a decrease in a vshy1 strain (Fig. 3B). Similar results were
obtained when whole cells were labelled in the presence of a
speci¢c inhibitor of cytoplasmic translation (cycloheximide).
This marked increase in newly synthesised COX subunits
compared to wild-type cells possibly re£ects a compensatory
attempt of the cell to restore full respiratory capacity. This
increased translation is not due to an increase in amount of
mitochondria, because in the pulse-chase experiment in iso-
lated mitochondria the amount of protein was kept constant
and still there was an increased translation. The increased
mitochondrial translation is not restricted to COX subunits
but holds for all the mitochondrially encoded gene products,
suggesting an increase of transcript levels. It has been demon-
strated in S. cerevisiae that the increase in transcript levels
which occurs upon release from glucose repression is mainly
caused by an increased transcription and not by an increased
mitochondrial DNA replication [29]. Despite the signi¢cantly
increased translation there is still not a full restoration of
COX. This increased translation of mitochondrially encoded
subunits, however, explains the increase of complex III activ-
ity in a vshy1 strain [16]. A net increase of in vitro mtDNA
translation products can also be observed in SURF1 null ¢-
broblasts (data not shown). Because synthesis is higher but
steady-state levels are lower, this implies that there is an in-
creased breakdown of the newly synthesised subunits, other-
wise steady-state levels should also be increased in a vshy1
strain.
To study the assembly of COX in more detail we performed
a pulse-chase experiment in combination with 2D electropho-
resis. Mitochondrially encoded gene products were selectively
labelled by treating cells with cycloheximide. Incorporation of
label into the individual subunits and holo-enzyme can then
be resolved and quanti¢ed (Fig. 4). When we focus on Cox3p
Fig. 1. Steady-state levels of COX in a vshy1 and its corresponding
wild-type strain (W303). Western blot analysis of blue native two-di-
mensional gels were incubated with monoclonal antibodies against
subunit I (Cox1p), subunit II (Cox2p) and subunit III (Cox3p) of
COX. Holo-cytochrome c oxidase is indicated as COX. Arrows in-
dicate low molecular weight immunoreactive species (see also text).
Molecular weights in the ¢rst dimension based on the molecular
mass of known complexes: prohibitin (1000 kDa), ATP synthase
(750 kDa) and COX (200 kDa) are indicated. In the second dimen-
sion a 10 kDa protein ladder was used (Gibco), the 50 kDa stan-
dard can be recognised by the longer mark.
Fig. 2. The ‘in-gel’ COX activity and ATP synthase activity assays of a vshy1 and W303 strain. A: The top part of the gel was stained for
ATP synthase activity and the bottom part was stained for COX activity (see also Section 2). B: Quanti¢cation of the gel bands was done us-
ing the computer program Image Quant0. The horizontal axis displays distance on the gel (mm), the vertical axis represents absorbance of the
gel in arbitrary units. Because the ATP synthase activity gives white precipitates in the gel this gives a negative absorbance on the gel.
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and compare the wild-type cells with the vshy1 cells, three
main di¡erences can be observed. First there is more smearing
in a vshy1 strain. Possibly this smear might represent incor-
rectly assembled, partially aggregated forms. Second there is
more label in unassembled subunits in the shy1-disruptant
strain. Third there is less label incorporated in holo-enzyme
in vshy1 cells compared to wild-type cells. In the shy1-disrup-
tant strain label is much slower incorporated into holo-COX.
This leads to the conclusion that the assembly of COX is
impaired when Shy1p is not present. This is the ¢rst direct
evidence that Shy1p is involved in COX assembly.
It has been demonstrated that mutants that have a bc1
complex activity of 30% of the wild-type enzyme still display
75% growth rate of the wild-type strain on glycerol medium
and even mutants that have only 5% of the wild-type activity
still show growth on glycerol [30]. Because COX has a control
strength rather similar to the bc1 complex (approximate 0.2)
[31] this means that 30% of COX activity should be su⁄cient
to sustain approximately normal mitochondrial respiration
and growth. The SHY1-disruptant strain displays a COX ac-
tivity which is approximately 30% of that of control cells, yet
vshy1 cells completely fail to grow on non-fermentative car-
bon sources. These ¢ndings strongly suggest that additional
factors contribute to the lack of growth on non-fermentative
carbon sources. Possibly the imbalance of subunits and the
handling of unassembled products that might a¡ect the mito-
Fig. 3. Synthesis of mitochondrially encoded proteins. A: Isolated mitochondria of wild-type (W303) and shy1 null mutant cells were labelled
with [35S]methionine for 20 min. 25 Wg of proteins were loaded on a gel and separated by SDS^PAGE. B: Labelled mitochondrial translation
products were separated by SDS^PAGE and blotted to nitrocellulose. First, labelled proteins were detected using a phosphorimager and subse-
quently the same blot was incubated with Cox2p and Cox3p antibodies to detect steady-state levels of these subunits.
Fig. 4. Synthesis, stability and assembly of mitochondrially encoded
Cox3p. Wild-type (W303) and shy1 null mutant cells were pulse-la-
belled with [35S]methionine for 10 min and 30 min in the presence
of cycloheximide. After adding a large excess of unlabelled methio-
nine, the cells were chased for 30 min and 60 min. Mitochondrial
pellets were run on 2D-PAGE as described before. Labelled proteins
were detected using a phosphorimager. Lines indicate the electro-
phoretic mobility of holo-cytochrome c oxidase (COX) and unas-
sembled subunits. Note: only the parts of the gels containing Cox3p
are shown.
Fig. 5. Prohibitin complex levels are increased in a vshy1 mutant
compared to wild-type cells (W303). Western blots of 2D gels (as
described before) were incubated with an anti-prohibitin antibody
(anti-Phb1p). For better comparison, the blots were also incubated
with Cox1p, Cox2p, Cox3p antibodies and a polyclonal antibody
against F1-ATP synthase.
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chondrial inner membrane integrity is such an additional fac-
tor contributing to the growth phenotype. It has been dem-
onstrated that prohibitins form an assembly chaperone com-
plex that is capable of binding newly synthesised COX
subunits [26]. This prohibitin complex may play a particularly
important role in situations in which there is an imbalance of
mitochondrially or nuclear encoded subunits. For this reason
we compared the amount of prohibitin complex in the vshy1
strain. In support of this idea is the ¢nding of a distinct in-
crease of the prohibitin complex in the vshy1 strain compared
with wild-type (Fig. 5).
In order to obtain information about the molecular organ-
isation of Shy1p we performed two-dimensional electropho-
retic analyses. After isolation of wild-type and vshy1 strain
mitochondria, proteins were separated using 2D-PAGE. After
transfer to nitrocellulose, blots were probed with an anti-
Shy1p antibody (Fig. 6A). In the wild-type cells, a speci¢c
signal of the expected molecular weight (45 kDa) appeared.
However, in the (native) ¢rst dimension Shy1p runs as high
molecular weight complex of about 250 kDa, implying that
Shy1p is associated with other components (or itself) in order
to form a high molecular weight complex. To con¢rm this
result we transformed a vshy1 strain with a HA-tagged
Shy1 protein. In this case the major immunoreactive spot of
Shy1p has a molecular weight of 250 kDa in the ¢rst dimen-
sion (Fig. 6B). There are also minor spots of approximately
50 kDa and 100 kDa, which possibly re£ect Shy1p monomer
and dimer respectively. Although Shy1p behaved as a mono-
mer by sedimentation in sucrose gradient [16], the mild solu-
bilisation and conditions of protein separation used in 2D-
PAGE allowed detection of a high molecular weight complex.
To obtain information about the molecular status of the
human Surf1p, we carried out a 2D blot of human ¢broblasts
that had been transfected with a HA-tagged SURF1 construct
(Fig. 7). A high molecular weight spot and two lower molec-
ular weight species possibly corresponding with the monomer
and dimer can be observed. When the same blot was probed
with anti-COX antibodies, material reactive with anti-Cox2p
antibody migrated at the same high molecular weight as the
Surf1p complex. Although it is attractive to speculate that
Cox2p may be associated with a high molecular weight
SURF1 complex, direct veri¢cation must await more rigorous
assays for the presence of such a complex and for evidence of
interactions between the proteins. We have attempted to ob-
tain additional information on components associating with
Surf1p, by co-immunoprecipitation experiments using the C-
terminal antibody (cf. Surf1p [15]). Unfortunately, however,
under the mild non-denaturing conditions necessary for dem-
onstrating associations, we were unable to precipitate Surf1p
(results not shown). The nature of these interactions is still not
clear, but the co-migration of Cox2p with one of the SURF1
complexes suggests an interaction with this COX subunit. A
Cox2p interaction would make sense because from studies in
human ¢broblasts it has been implied that the COX assembly
was disturbed at the level of Cox2p incorporation [15]. Fur-
ther investigations are underway to address this question.
Our data clearly demonstrate that Shy1p is a COX assem-
bly chaperone. It forms high molecular weight complexes,
indicating interactions with other mitochondrial components,
among these possibly Cox2p. Still the exact molecular work-
ing mechanism of Shy1p (and Surf1p) needs to be resolved.
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Fig. 6. Western blot of 2D-PAGE of mitochondrial samples from
W303 and vshy1 strains. A: Blots were probed with anti-Shy1p
polyclonal antibody (Shy1p). B: 2D-PAGE blots of mitochondria
from a wild-type strain (W303) and a vshy1 strain transformed with
a SHY construct tagged with a HA epitope (see Section 2). The
blots were incubated with antibodies against Cox1p, Cox2p and
HA. Molecular weight markers are used as in Fig. 1, 20 kDa, 40
kDa and 60 kDa are indicated.
Fig. 7. Human Surf1p also appears in a high molecular weight com-
plex. Fibroblasts, from patients with surf1 null mutation, transfected
with SURF1-HA were analysed by Western blots of 2D-PAGE gels,
probed with an anti-human Cox1 and Cox2p antibody (A) and with
anti-Surf1p antibody (B). COX refers to holo-cytochrome c oxy-
dase.
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